Comparison of the effect of Yasmin and Cyproteron compound on metabolic syndrome in women with confirmed polycystic ovary syndrome
Phase 3
- Conditions
- Metabolic Syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201204171760N17
- Lead Sponsor
- Vice Chancellor for Research and Technology, Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
18-35 years old nonsmoker women with polycystic ovary syndrome and metabolic syndrome. Exclusion criteria: hyperprolactinemia; hypothyroidism; diabetes; doing regular intense exercise; taking diet or herbal treatment, non-steroidal anti-inflammatory drug, diuretics, or hormone therapy during last 3 months.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in indices of metabolic syndrome. Timepoint: After cessation of treatment. Method of measurement: Clinical examination, lab.
- Secondary Outcome Measures
Name Time Method Side effects of drugs (such as complaints of headaches and spoting). Timepoint: During drug use. Method of measurement: Self-reported.